RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sai Diwakar Kuchibhotla

Nurse Practitioner · Manassas, VANPI 1548570039

Payments from drug & device makers

$631in general payments, 2019–2025

Across 29 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ANI Pharmaceuticals, Inc.$78
  • Otsuka America Pharmaceutical, Inc.$66
  • Mallinckrodt Hospital Products Inc.$62
  • Amgen$53
  • Novo Nordisk$44
  • Fresenius USA Marketing, Inc.$41
  • plus $286 from 11 others

What the payments were for

  • Food & beverage$61097%
  • Education$203%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ANI Pharmaceuticals, Inc.3$78
Otsuka America Pharmaceutical, Inc.3$66
Mallinckrodt Hospital Products Inc.2$62
Amgen2$53
Novo Nordisk3$44
Fresenius USA Marketing, Inc.2$41
Akebia Therapeutics Inc2$37
AstraZeneca2$36
Bayer1$33
Travere Therapeutics, Inc.1$27
Ardelyx, Inc.1$26
Lilly USA, LLC1$26
Kowa Pharmaceuticals America, Inc.2$25
Alnylam Pharmaceuticals Inc.1$22
Vifor Pharma, Inc.1$21
OPKO Pharmaceuticals, LLC1$20
Otsuka Pharmaceutical Development & Commercialization, Inc.1$14

How this compares

$631 in reported general payments places this provider in the 75th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia →

Medicare billing

Part B allowed, 2024
$45,673
Medicare patients
385
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir12$68

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Manassas

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →